General Information of DTT (ID: TTUCPMY)

DTT Name Tenascin (TNC) DTT Info
Gene Name TNC

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Clinical Trial Drug(s)
Discontinued Drug(s)
3 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
F-16-IL-2 fusion protein DMJ4BKT Solid tumour/cancer 2A00-2F9Z Phase 2 [1]
F-16-131I DM49BX1 Haematological malignancy 2B33.Y Phase 1/2 [2]
8H9 DMQ789Z Brain cancer 2A00 Phase 1 [3]
------------------------------------------------------------------------------------
1 Discontinued Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
131I-81C6 DMVO0LU Brain cancer 2A00 Terminated [4]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 National Cancer Institute Drug Dictionary (drug id 674718).
2 Tumor-Associated Fibroblasts and their Matrix. Springer. Margareta M. Mueller,Norbert E. Fusenig, 2011. Page(775).
3 In vitro and in vivo cytotoxic activities of recombinant immunotoxin 8H9(Fv)-PE38 against breast cancer, osteosarcoma, and neuroblastoma. Cancer Res. 2004 Feb 15;64(4):1419-24.
4 Human IgG2 constant region enhances in vivo stability of anti-tenascin antibody 81C6 compared with its murine parent. Clin Cancer Res. 1998 Oct;4(10):2495-502.